Updated cutaneous T-cell lymphoma TNMB staging criteria fail to identify patients with Sézary syndrome with low blood burden.

Authors

Lauren P Chrisman
Payton Fors Trimark
Yanzhen Pang
David Randall Pease
Maria Estela Martinez-Escala
William Nguyen, Lehigh Valley Health NetworkFollow
Rony Fernandez
Teresa L Griffin
Lindsey Ayanruoh
Madeline J Hooper
Xiaolong A Zhou
Lucy Fu
Kristy L Wolniak
Joan Guitart

Publication/Presentation Date

8-22-2024

Abstract

Comparison of the 2007 EORTC/ISCL and the 2022 EORTC/ISCL/USCLC blood staging guidelines for cutaneous T-cell lymphoma at a single institution reveals the newer guidelines fail to detect a subset of patients with Sézary syndrome with low blood burden.

Volume

144

Issue

8

First Page

914

Last Page

917

ISSN

1528-0020

Published In/Presented At

Chrisman, L. P., Trimark, P. F., Pang, Y., Pease, D. R., Martinez-Escala, M. E., Nguyen, W. Q., Fernandez, R., Griffin, T. L., Ayanruoh, L., Hooper, M. J., Zhou, X. A., Fu, L., Wolniak, K. L., & Guitart, J. (2024). Updated cutaneous T-cell lymphoma TNMB staging criteria fail to identify patients with Sézary syndrome with low blood burden. Blood, 144(8), 914–917. https://doi.org/10.1182/blood.2023023584

Disciplines

Medical Education | Medicine and Health Sciences

PubMedID

38848513

Department(s)

USF-LVHN SELECT Program, USF-LVHN SELECT Program Students

Document Type

Article